Why the study?
Does fenoprofen inhibit platelet aggregation compared to aspirin and phenylbutazone in vitro and in vivo?
Does fenoprofen inhibit platelet aggregation compared to aspirin and phenylbutazone in vitro and in vivo?
Fenoprofen demonstrates inhibitory effects on platelet aggregation in preclinical models.
Answers are grounded in this paper and cite their sources.
Fenoprofen may inhibit platelet aggregation in preclinical models; hypothesis-generating and should not yet change practice.
Fenoprofen sodium (a new antiinflammatory drug), aspirin, and phenylbutazone were compared with respect to their inhibitory activity on platelet function. These compounds inhibit collagen-induced platelet aggregation both in vitro (human, rabbit, and guinea pig) and in vivo (rabbit and guinea pig).
No takes yet. Share an insight, caveat, or question.
Herrmann et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: